Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.850
-0.050 (-2.63%)
At close: Nov 20, 2026, 4:00 PM EST
1.990
+0.140 (7.57%)
After-hours: Nov 20, 2026, 7:55 PM EST
Cerus Employees
As of December 31, 2025, Cerus had 275 total employees, including 261 full-time and 14 part-time employees. The number of employees increased by 1 or 0.36% compared to the previous year. That makes Cerus the 24,530th largest employer in the world and 3,129th in the United States.
Employees
275
Change (1Y)
1
Growth (1Y)
0.36%
Revenue / Employee
$823,880
Profits / Employee
-$26,596
Market Cap
373.62M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 275 | 1 | 0.36% | 261 | 14 |
| Dec 31, 2024 | 274 | -6 | -2.14% | 258 | 16 |
| Dec 31, 2023 | 280 | -23 | -7.59% | 268 | 12 |
| Dec 31, 2022 | 303 | 16 | 5.57% | 291 | 12 |
| Dec 31, 2021 | 287 | 21 | 7.89% | 274 | 13 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Viemed Healthcare | 1,490 |
| InfuSystem Holdings | 473 |
| Treace Medical Concepts | 450 |
| AVITA Medical | 226 |
| Anteris Technologies Global | 174 |
| 908 Devices | 172 |
| Senseonics Holdings | 130 |
| BrainsWay | 129 |
CERS News
- 4 days ago - Cerus Corporation to Participate in Upcoming Investor Conferences - Business Wire
- 10 days ago - Cerus Corporation to Participate in the 17th Annual Craig-Hallum Alpha Select Conference - Business Wire
- 19 days ago - Cerus files $150M mixed securities shelf - TheFly
- 19 days ago - Cerus Earnings Call Transcript: Q3 2026 - Transcripts
- 19 days ago - Cerus Earnings release: Q3 2026 - Filings
- 19 days ago - Cerus Quarterly report: Q3 2026 - Filings
- 19 days ago - Cerus' blood-safety system meets main goal in late-stage trial - Reuters
- 19 days ago - Cerus says primary efficacy endpoint met in Phase 3 RedeS trial - TheFly